Author: Tim Gunn

Cancer Research UK today announced the appointments of Rakshit Kapoor and Hitesh Thakrar to its Council of Trustees, the charity’s board of directors.

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we’re going to stop it.

We’ve helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months. 

The “potentially life-saving” immunotherapy drug pembrolizumab is now recommended for some people with early triple negative breast cancer in England and Wales.

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She’s using all she’s learned to create better treatments for solid tumours in children.